Thermo Fisher Scientific Inc. (NYSE:TMO) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET
Company Participants
Rafael Tejada - Vice President, Investor Relations
Marc Casper - Chairman, President & Chief Executive Officer
Stephen Williamson - Senior Vice President & Chief Financial Officer
Conference Call Participants
Michael Ryskin - Bank of America
Rachel Vatnsdal - JPMorgan
Jack Meehan - Nephron Research
Doug Schenkel - Wolfe Research
Tycho Peterson - Jefferies
Puneet Souda - Leerink Partners
Operator
Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2024 Fourth Quarter Conference call. My name is Ezra, and I will be your coordinator today. [Operator Instructions]
I would like to introduce our moderator for the call, Mr. Rafael Tejada, Vice President, Investor Relations. Mr. Tejada, you may begin the call.
Rafael Tejada
Good morning, and thank you for joining us. On the call with me today is Marc Casper, our Chairman, President and Chief Executive Officer; and Stephen Williamson, Senior Vice President and Chief Financial Officer. Please note this call is being webcast live and will be archived on the Investors section of our website, thermofisher.com, under the heading News, Events & Presentations until February 13, 2025. A copy of the press release of our fourth quarter and full year 2024 earnings is available in the Investors section of our website under the heading Financials.
So, before we begin, let me briefly cover our Safe Harbor statement. Various remarks that we may make about the company’s future expectations, plans and prospects, constitute forward-looking statements for purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the company’s most recent annual report on Form 10-K and subsequent quarterly report